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Abstract
Background: Pre-clinical detection of atherosclerosis enables personalized preventive strategies in asymptomatic
individuals. Cardiovascular magnetic resonance (CMR) has evolved as an attractive imaging modality for studying
atherosclerosis in vivo. Yet, the majority of aortic CMR studies and proposed sequences to date have been
performed at 1.5 tesla using 2D BB techniques and a slice thickness of 4–5 mm. Here, we evaluate for the first
time the reproducibility of an isotropic, T1-weighted, three-dimensional, black-blood, CMR VISTA sequence
(3D-T1-BB-VISTA) for quantification of aortic wall characteristics in healthy, young adults.
Methods: In 20 healthy, young adults (10 males, mean age 31.3 years) of the AMBITYON cohort study the
descending thoracic aorta was imaged with a 3.0 T MR system using the 3D-T1-BB-VISTA sequence. The inter-scan,
inter-rater and intra-rater reproducibility of aortic lumen, total vessel and wall area and mean and maximum wall
thickness was evaluated using Bland-Altman analyses and Intraclass Correlation Coefficients (ICC). Based on these
findings, sample sizes for detecting differences in aortic wall characteristics between groups were calculated.
Results: For each studied parameter, the inter-scan, inter-rater and intra-rater reproducibility was excellent as
indicated by narrow limits of agreement and high ICCs (ranging from 0.76 to 0.99). Sample sizes required to detect
a 5 % difference in aortic wall characteristics between two groups were 203, 126, 136, 68 and 153 per group for
lumen area, total vessel area and vessel wall area and for mean and maximum vessel wall thickness, respectively.
Conclusion: The 3D-T1-BB-VISTA sequence provides excellent reproducibility for quantification of aortic wall
characteristics and can detect small differences between groups with reasonable sample sizes. Hence, it may be
a valuable tool for assessment of the subtle vascular wall changes of early atherosclerosis in asymptomatic
populations.
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Background
Cardiovascular disease (CVD) remains a major cause of
morbidity and mortality worldwide [1]. Atherosclerosis,
the underlying pathophysiological condition, is a slowly
progressive, inflammatory process that causes adverse
remodelling of the arterial wall. The slowly progressive
changes in the arterial wall attributed to atherosclerosis
provide a window of opportunity for its pre-clinical
detection.
Cardiovascular magnetic resonance (CMR) has evolved
as an attractive imaging modality for studying athero-
sclerosis in vivo [2–4]. The descending and abdominal
aorta, the artery where atherosclerosis is known to de-
velop first [5], has been the subject of a number of studies
using MR [6–8]. To date, most CMR studies have used
2D sequences at a field strength of 1.5 tesla (T), limiting
both spatial resolution and aortic coverage due to time
constraints. Nowadays, the widespread availability of 3 T
MR scanners has led to increased signal-to-noise ratio
vessel wall imaging [9]. Furthermore, there is ongoing
development of sequences that aim to optimize image
quality whilst covering a larger extent of the aorta with
clinically acceptable scan duration [10–12].
One of the most promising CMR sequences that is
increasingly being applied in various vascular areas is a
3-dimensional (3D), T1-weighted (T1), black-blood (BB),
turbo-spin-echo (TSE) sequence with variable flip angles
(3D-T1-BB-VISTA) [6, 13]. This sequence allows for an
isotropic depiction of the vessel wall in an acceptable
scan time with (sub)-millimetre spatial resolution. Be-
cause of the T1-weighting, the VISTA sequence is also
sensitive to the effects of contrast agent administration
[13]. Hence, the 3D-T1-BB-VISTA sequence may be at-
tractive for the detection of atherosclerosis in early life,
when vascular wall abnormalities are still subtle.
The reproducibility of the 3D-T1-BB-VISTA sequence
has been evaluated before, yet in an older population
with known CVD and using CMR hardware from a dif-
ferent vendor as compared to the current study [6]. The
objective of this study was to investigate the inter-scan
and inter-rater as well as intra-rater reproducibility of
3D-T1-BB-VISTA CMR in healthy, young adults for as-
sessment of vascular wall characteristics of the descend-
ing thoracic aorta. Based on the reproducibility, sample
sizes for (therapeutic) trials were calculated by determin-
ing the number of participants needed to detect pre-
specified differences in aortic wall characteristics between
groups.
Methods
Study population and design
The study cohort consisted of healthy, young adults
participating in the Atherosclerosis Monitoring and
Biomarker measurements In The YOuNg (AMBITYON)
study. The AMBITYON study, initiated in 2014, is a pro-
spective, ongoing, single centre cohort study that evalu-
ates the interplay between classical cardiovascular risk
factors, plasma markers of inflammation, markers of
activated circulating cells and atherosclerosis burden
(visualized using CMR) in the development of atheroscler-
osis in young adulthood. The aim of the AMBITYON
study is to identify key drivers of atherosclerosis and
individuals who are at high risk of developing clinically
manifest atherosclerosis later in life. The AMBITYON
study is registered in the Netherlands National Trial
Register under number 4742. The AMBITYON study cur-
rently comprises approximately 130 healthy, young adults
who live in a domestic area near the city of Utrecht,
Leidsche Rijn. Individuals were eligible for participation in
the AMBITYON study if they were between 25 and
35 years of age, did not have a prior history of CVD and
did not use cardiovascular preventive medication. In
addition, participants with cardiac arrhythmias or with ab-
solute or relative contra-indications to MR were excluded.
For the present study, 20 out of 130 AMBITYON partici-
pants were randomly selected. The institutional review
board of the University Medical Center Utrecht approved
the study and written informed consent, including consent
to publish, was obtained from all participants before
enrolment.
The study design is presented in Fig. 1. In short, we
acquired three 3D-T1-BB-VISTA scans of the descend-
ing thoracic aorta; all scans were performed on the same
day. First, a non-contrast enhanced scan was performed
(scan 1). Subsequently, participant and table were repo-
sitioned and new survey and calibration scans were ac-
quired. Thereafter, a second non-contrast enhanced scan
was performed (scan 2). After the second scan, a third
late gadolinium enhanced (contrast-enhanced) scan was
performed, without repositioning or re-planning, 10 mi-
nutes after administration of 0.1 mmol/kg gadobutrol
(Gadovist, Bayer Healthcare, Berlin, Germany) (scan 3).
Scans 1 and 2 were used to evaluate the inter-scan repro-
ducibility of the 3D-T1-BB-VISTA sequence and scans 2
and 3 to assess inter-rater and intra-rater reproduci-
bility (for both the non-contrast enhanced and contrast-
enhanced scans). Total imaging time for each 3D-T1-BB-
VISTA scan was 7 min and 38 s. Total imaging time for
each participant was approximately 60 min.
CMR protocol
Both CMR scans were performed on a 3.0 T multi-
transmit, clinical MR Scanner (Achieva, Software Re-
lease 5.1.7, Philips Healthcare, Best, the Netherlands).
Images of the descending thoracic aorta were obtained
with the subject placed in a supine position using a 32-
channel phased array cardiac coil for signal reception.
Images were acquired during free breathing without
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ECG gating. The coil consisted of two flexible coils that
are situated posterior and anterior to the participant.
The posterior coil part is embedded in a housing mat-
tress that is integrated on the MR table top.
Following a survey and B1 calibration scan, the descend-
ing thoracic aorta was imaged in the sagittal orientation
using the 3D-T1-BB-VISTA sequence with Spectral Atten-
uated Inversion Recovery (SPAIR) fat suppression. All ac-
quisition planes of the survey images were used to locate
the descending thoracic aorta and plan the 3D-T1-BB-
VISTA sequence. The cranial boundary of the field of view
(FOV) was positioned at the top of the aortic arch; the
caudal boundary ended at the most distal margin of the
cardiac coil, covering approximately 35 cm of aorta. Other
imaging parameters of this sequence included: number of
slices: 75, FOV: 350x302x45 mm, acquired isotropic voxel
size: 1.20×1.20×1.20 mm3, reconstructed isotropic voxel
size: 0.60×0.60×0.60 mm3, matrix: 292×252, echo spacing:
3.0 ms, echo train length: 37 + 8 start-up echoes, refocus-
ing flip angle scheme (Fig. 2; αmin = 20°, αmax = 112°),TSE
factor: 45, TR: 1000 ms, TE: 33 ms, Flip Angle: 90°,
number of signal averaging (NSA; used to reduce free
induction decay artefacts): 2, slice orientation: sagittal.
Additionally, a sensitivity encoding (SENSE) parallel im-
aging algorithm was used to allow for faster image acquisi-
tion. The imaging parameters were held constantly for all
Fig. 1 Flow chart of study design. Graphic overview of study design and of inter-scan and non-contrast enhanced and contrast-enhanced inter-rater
and intra-rater image analysis to determine reproducibility
Fig. 2 Refocusing flip angle scheme. Refocusing flip angle scheme for 3D-T1-BB-VISTA sequence. Parameters: αmin: 20°, αmax: 112°, echo spacing:
3.0 ms, echo train length: 37 + 8 start-up echoes
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three scans. Adequate blood signal suppression was
achieved by spins dephasing due to blood flow in the read
out direction. To ensure adequate blood suppression under
slow flow conditions, 8 start-up echoes were added. This
number of start-up echoes was empirically determined in
sequence optimization experiments (data not shown) as
well as based on a prior study [14].
CMR image analysis
The sagittal source images of the 3D-T1-BB-VISTA were
reconstructed to approximately 300 slices of 1.2 mm thick-
ness in the transverse plane using customized built-in soft-
ware (Achieva, Philips Healthcare, Best, the Netherlands).
Examples of the original sagittal source images of the 3D-
T1-BB-VISTA acquisition as well as reconstructed plain
and traced transverse images of all three acquisitions are
displayed in Fig. 3. Subsequently, all 3D-T1-BB-VISTA
source images and reformations were further analysed
using a customized software program designed for meas-
uring geometric dimensions of vascular walls (Vessel
Mass, release 5.1, Laboratory for Clinical and Experimen-
tal Image processing, The Netherlands) [15]. Due to the
limited craniocaudal coverage of the cardiac coil, we ana-
lysed the slices from the origin of the descending thoracic
aorta to the origin of the celiac trunk. We did not analyse
the aortic region below the celiac trunk since the signal to
noise ratio (SNR) of this region is insufficient when using
a cardiac coil. As such, the image quality is deemed insuf-
ficient. In each subject, 1 slice per centimeter of cranio-
caudal coverage was assessed for geometric parameters.
The starting point was the origin of the descending thor-
acic aorta, just distal to the aortic arch. The endpoint was
the last imaging slice before the origin of the first major
branch of the abdominal aorta, the celiac trunk. Matching
and co-registering of slices across the scans was per-
formed using slice numbers and these two anatomical
landmarks.
Images were analysed according to a standardized
protocol. First, an experienced radiologist (TL) visually
evaluated the selected slices for overall image quality
and vascular wall delineation. An image was of sufficient
quality if the signal and contrast to noise ratio allowed
for a clear visualisation of ≥180° of (i.e., ≥50 %) of
the contours of the aortic wall. This method was
based on prior studies as well as on the raters’ training set
[12, 16]. Insufficient images were removed from analysis.
To obtain the most optimal depiction of the aortic wall,
we enlarged the remaining images to 300 % of their
Fig. 3 Example of 3D-T1-BB-VISTA acquisition. Examples of the original sagittal and reconstructed plain and traced transverse images of the
descending thoracic aorta obtained with the 3D-T1-BB-VISTA sequence in a 32 year old female participant. Acquisitions 1 and scan 2 are identical
non-contrast enhanced acquisitions at different time points. Acquisition 3 is a post-contrast acquisition. Aortic wall thicknesses for this slice were
1.52 mm, 1.53 mm and 1.51 mm respectively
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original proportions and adjusted the brightness and con-
trast settings (window width: 350–400, image contrast:
40-55 and image brightness: 25–35), all in Vessel Mass.
The choice for these features was based on prior studies
and the raters’ training set [12, 16–18]. These parameters
were held constantly for all analyses. Next, the lumen and
outer (adventitial) contours of each image were manually
traced. Based on these contours, the software program
automatically calculated for each analysed slice the aortic
lumen, aortic total vessel and aortic wall areas (cm2) and
the mean and maximum aortic wall thickness (mm). Ves-
sel Mass measures wall thickness based on the centreline
method, which has previously been validated [15]. In
short, wall thickness measurements are acquired at 100
equally spaced positions along the aortic wall circumfer-
ence. This generates the mean aortic wall thickness for
each slice. An example is displayed in Fig. 3. For each
participant, the mean of each aortic wall parameter was
calculated by summing the value for all slices and dividing
it by the number of analysed slices. Additionally, to adjust
for differences in arterial size within each participant, a
normalized wall index, which is the ratio between the
aortic wall and the aortic total vessel area (wall area/total
vessel area), was calculated. An illustration of aortic wall
characteristic quantification is displayed in Fig. 4.
Inter-scan and inter-rater and intra-rater reproducibility
To determine inter-scan reproducibility, an experienced
rater (AE, 2 years of image analysis experience), analysed
the images of scans 1 and 2 in all participants in a
computer-based random order. In addition, for determin-
ation of non-contrast enhanced intra-rater reproducibility,
AE analysed the images of scan 2 for a second time in 10
of the 20 participants. Furthermore, for determination of
intra-rater reproducibility of the contrast-enhanced scan
(scan 3), AE analysed the images of scan 3 twice in the
same 10 subjects. These 10 subjects were chosen using a
computer-based random number generator that produced
10 numbers between 1 and 20. Recall bias was reduced to
a minimum by using a time frame of approximately
90 days between the first and second image analysis.
To determine inter-rater reproducibility, another rater
(BB, 3 years of image analysis experience) independently
analysed the images of the 3D-T1-BB-VISTA scans 2
and 3 in the same 10 subjects as AE (Fig. 1). Except for
study number, both raters were blinded for participant
Fig. 4 Quantification of aortic wall characteristics. Schematic representation of quantification of descending thoracic aortic wall characteristics.
The aortic lumen and outer contours are manually traced. a represents a graphic illustration of tracing of the inner and outer contour as well as a
thickness measurement. b represents an in vivo example of a traced transversal image of the descending thoracic aorta (non-contrast enhanced).
c represents the definitions and quantification methods of the studied aortic wall characteristics
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characteristics and each other’s results. The blinding was
assured by replacing each participant’s image identifier
with a pre-assigned unique study number. For the inter-
scan, inter-rater and intra-rater reproducibility, matching
and co-registering of slices across the scans was performed
using slice numbers and the two anatomical landmarks.
Data analysis
Baseline
All aortic wall characteristics under study were normally
distributed and thus expressed as means ± standard devi-
ation (SD). The aortic wall characteristics are presented
at participant level.
Reproducibility
Inter-scan, inter-rater and intra-rater reproducibility
were evaluated for all aortic wall characteristics under
study. First, absolute agreement was assessed using Bland-
Altman analysis. In addition, Intra-class Correlation
Coefficients (ICC) with 95 % confidence intervals were
calculated. The ICC was based on a 2 way random effects
model of variance for assessing absolute agreement of sin-
gle measures. An ICC of <0.4 was considered to indicate a
poor reproducibility, an ICC between 0.4 and 0.75 was
considered to indicate a fair to good reproducibility and
an ICC > 0.75 was considered to indicate an excellent re-
producibility. All reproducibility analyses were performed
at participant level and carried out using SPSS version
21.0 (IBM, Armonk, IL, USA).
Sample size calculations
The means and SDs of the aortic wall characteristics
under study were used to calculate the sample size needed
to detect a difference of 15 %, 12 %, 10 %, 7 % or 5 % be-
tween 2 groups in each of the studied aortic wall charac-
teristics. The choice of these values was based on
published literature and the range of expected differences
in aortic vessel wall parameters [2, 19]. Each value was
corrected for its accompanying inter-scan difference. Sam-
ple size calculations were based on a two-sided unpaired
t-test and performed with a power of 80 % and an alpha
level of 5 %. Sample sizes were calculated using PASS ver-
sion 14.0 (NCSS Statistical Software, Kaysville, UT, USA).
Results
Image analysis characteristics
Each participant completed all three 3D-T1-BB-VISTA
scans; none of the selected images were excluded for
analysis due to poor image quality. On average, the
length of the descending thoracic aorta from its origin
to celiac trunk was 22 cm. Since 1 slice per centimetre
of craniocaudal coverage was analysed, on average 22 slices
were analysed per participant. In total, 447 slices were ana-
lysed for the inter-scan reproducibility and 203 slices for
both the inter-rater and intra-rater reproducibility (for
both the non-contrast enhanced and contrast-enhanced
acquisitions).
Participant and aortic wall characteristics
The mean age of the participants was 31.3 years (±2.98);
50 % was male (n = 10). The mean values and SDs of the
aortic wall characteristics under study are presented in
Table 1. Of note, only the mean values of the mean aortic
lumen and total vessel area were significantly different be-
tween the non-contrast enhanced and contrast-enhanced
acquisitions.
Inter-scan reproducibility
The results of the inter-scan reproducibility are presented
in Table 2 and in Additional file 1 A-F. In summary, the
mean differences of the mean aortic wall area and of the
mean and maximum aortic wall thickness were 0.01 cm2
(±0.03), 0.01 mm (±0.05) and 0.04 mm (±0.17) respect-
ively. Their lower and upper limit (LOA) values ranged
from −0.05 to 0.07 cm2, from −0.08 to 0.11 mm and
from −0.29 to 0.37 mm respectively. The inter-scan ICCs
of all aortic wall characteristics were >0.75, indicating
excellent reproducibility.
Inter-rater reproducibility
Table 3 and Additional file 2 and Additional file 3 A-F
display the results of the inter-rater reproducibility. In
summary, in the non-contrast enhanced images, the mean
difference of the mean aortic wall area was 0.00 cm2
(±0.02) (LOA: −0.04, 0.04) as opposed to a mean differ-
ence of 0.03 cm2 (±0.06) (LOA: −0.10, 0.15) in the con-
trast-enhanced images. Additionally, the mean differences
of the mean and maximum aortic wall thickness in the
non-contrast enhanced images were −0.01 mm (±0.02)







Mean (SD)a Mean (SD)a
- Mean aortic lumen area
(cm2)a,b
2.52 (0.38) 2.63 (0.40)
- Mean aortic total vessel
area (cm2)a,b
3.54 (0.47) 3.66 (0.49)
- Mean aortic wall area (cm2)a 1.02 (0.12) 1.05 (0.13)
- Mean aortic wall thickness
(mm)a
1.66 (0.15) 1.67 (0.15)
- Maximum aortic wall
thickness (mm)a
2.28 (0.23) 2.28 (0.28)
- Mean aortic WA/TVA ratioa 0.29 (0.02) 0.29 (0.03)
aSD: standard deviation. cm: centimeter. mm: millimeter. WA: wall area.
TVA: total vessel area
bsignificantly different between non-contrast enhanced and contrast-enhanced
aortic wall characteristics
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(LOA: −0.06, 0.03) and 0.14 mm (±0.13) (LOA: −0.11,
0.40) respectively. In the contrast-enhanced images, these
values were 0.03 mm (±0.11) (LOA: −0.18, 0.24) and
0.07 mm (±0.12) (LOA: −0.17, 0.31) respectively. All aortic
wall characteristics under study were highly reproducible
with ICCs of >0.80 for both the non-contrast enhanced as
well as the contrast-enhanced acquisitions.
Intra-rater reproducibility
Table 4 and Additional file 4 and Additional file 5 A-F
summarize the Bland-Altman analyses and ICCs for
the intra-rater reproducibility. In summary, in the non-
contrast enhanced images, the mean difference of the
mean aortic wall area was 0.01 cm2 (±0.03) (LOA: −0.05,
0.07) as compared to a mean difference of 0.02 cm2
(±0.02) (LOA: −0.03, 0.07) in the contrast-enhanced im-
ages. Furthermore, in the non-contrast enhanced images,
the mean differences of the mean and maximum aortic
wall thickness were 0.01 mm (±0.06) (LOA: −0.10, 0.13)
and 0.05 mm (±0.11) (LOA: −0.16, 0.25), respectively. In
the contrast-enhanced scans these values were 0.03 mm
(±0.05) (LOA: −0.07, 0.12) and 0.00 mm (±0.08) (LOA:
−0.16, 0.16) respectively. Additionally, the intra-rater ICCs
of the studied aortic wall characteristics were all >0.90 for
both non-contrast enhanced and contrast-enhanced ac-
quisitions, again indicating excellent reproducibility.
Sample size calculations
In Fig. 5, the results of the sample size calculations are
displayed. The sample sizes needed to detect a pre-
specified difference of 15 % between groups in mean
aortic wall area and mean and maximum aortic wall
thickness are 13, 8 and 11 per group respectively. In
addition, to detect the smallest pre-specified difference
between groups, namely a difference of 5 %, the required
sample sizes are 136, 68 and 153 for mean aortic wall
area and mean and maximum aortic wall thickness
respectively.
Table 2 Inter-scan reproducibility
ICCa 95 % CIa Mean difference (SD)a 95 % LOAa
- Mean aortic lumen area (cm2)a 0.98* 0.95, 0.99 −0.02 (0.08) −0.17, 0.14
- Mean aortic total vessel area (cm2)a 0.98* 0.96, 0.99 −0.01 (0.08) −0.17, 0.16
- Mean aortic wall area (cm2)a 0.97* 0.92, 0.99 0.01 (0.03) −0.05, 0.07
- Mean aortic wall thickness (mm)a 0.94* 0.87, 0.98 0.01 (0.05) −0.08, 0.11
- Maximum aortic wall thickness (mm)a 0.76* 0.50, 0.90 0.04 (0.17) −0.29, 0.37
- Mean aortic WA/TVA ratioa 0.94* 0.87, 0.98 0.00 (0.01) −0.01, 0.02
* P < .001
aICC: intraclass correlation coefficient (two-way random effects model assessing absolute of single measures). CI: confidence interval. LOA: limits of agreement.
WA: wall area. TVA: total vessel area
Table 3 Inter-rater reproducibility
ICCa 95 % CIa Mean difference (SD)a 95 % LOAa
Inter-rater (non-contrast enhanced)a
- Mean aortic lumen area (cm2)a 0.99* 0.88, 1.00 0.05 (0.06) −0.06, 0.17
- Mean aortic total vessel area (cm2)a 0.99* 0.93, 1.00 0.05 (0.07) −0.08, 0.19
- Mean aortic wall area (cm2)a 0.99* 0.98, 1.00 0.00 (0.02) −0.04, 0.04
- Mean aortic wall thickness (mm)a 0.99* 0.95, 1.00 −0.01 (0.02) −0.06, 0.03
- Maximum aortic wall thickness (mm)a 0.81* 0.40, 0.96 0.14 (0.13) −0.11, 0.40
- Mean aortic WA/TVA ratioa 0.98* 0.76, 0.99 −0.01 (0.00) −0.02, 0.00
Inter-rater (contrast-enhanced)
- Mean aortic lumen area (cm2)a 0.98* 0.92, 1.00 0.04 (0.08) −0.11, 0.20
- Mean aortic total vessel area (cm2)a 0.98* 0.91, 1.00 0.06 (0.08) −0.10, 0.22
- Mean aortic wall area (cm2)a 0.91* 0.70, 0.98 0.03 (0.06) −0.10, 0.15
- Mean aortic wall thickness (mm)a 0.81* 0.42, 0.95 0.03 (0.11) −0.18, 0.24
- Maximum aortic wall thickness (mm)a 0.88* 0.56, 0.97 0.07 (0.12) −0.17, 0.31
- Mean aortic WA/TVA ratioa 0.81* 0.40, 0.95 0.00 (0.02) −0.03, 0.04
*P < .001
aICC: intraclass correlation coefficient (two-way random effects model assessing absolute of single measures). CI: confidence interval. LOA: limits of. WA: wall area.
TVA: total vessel area
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Discussion
The present study demonstrated that the 3D-T1-BB-
VISTA sequence is highly reproducible and well-suited
for quantification of aortic wall characteristics in young
adults. The inter-scan, inter-rater and intra-rater limits
of agreement of all aortic wall characteristics under
study were narrow and the ICCs were all above 0.75,
indicating a low variability in measurement. Sample
sizes required to detect a 5 % difference between 2
groups were reasonable for all of the studied aortic
wall characteristics. Our results provide an important
first step in the process of determining the utility of
the 3D-T1-BB-VISTA sequence for preclinical detec-
tion and monitoring of atherosclerosis burden in early
adult life, when vascular wall abnormalities are still
subtle.
The gradually developing lesions in the arterial wall,
induced by atherosclerosis, offer an opening for its pre-
clinical detection. Unfortunately, currently used CV risk
scores are population based, yet do not conclusively
identify individuals at high-risk for developing clinically
manifest CVD [20]. Furthermore, they are predomin-
antly validated in people over 40 years of age [21]. The
American Heart Association (AHA) has recognized this
problem and underlined the need for enhanced assess-
ment of non-invasive methods for CVD risk evaluation
in young adults [21]. More detailed assessment of the
presence or absence of early atherosclerotic changes
may improve our understanding of the pathophysiology
of atherosclerosis, reveal important determinants and
may enhance CVD risk stratification, which is important
since identification of high-risk individuals at a young
age may enable early interventions to avert or delay the
onset of clinically manifest CVD.
Aortic atherosclerosis develops at an early age with
the occurrence of aortic wall thickening, a process that
precedes the development of discrete plaques by up to
several decades. The extent of aortic wall thickening and
plaque burden are known to be related to CV risk fac-
tors and events [2, 4, 8, 17–19, 22]. Moreover, character-
istics of the descending thoracic aortic wall highly relate
with those of the carotid arteries [8, 23]. Hence, aortic
atherosclerosis is conceived to be a relevant proxy meas-
ure of generalized atherosclerosis and possibly of specific
interest in young adults.
The assessment of aortic atherosclerosis using imaging
modalities is promising [2]. Of all the available modal-
ities for this purpose CMR has various advantages over
other imaging techniques. CMR is non-invasive, does
not rely on ionizing radiation, and is capable of large
anatomical coverage and superior soft tissue contrast
that offers the ability to directly visualize and accurately
assess various stages of aortic atherosclerosis. Prior stud-
ies have demonstrated a good agreement between CMR
and histology as well as transesophageal echocardiography
with regard to the presence and extent of atherosclerotic
plaques [2, 3, 8, 23]. Furthermore, Corti and co-authors
suggested, based on their reproducibility data, that 2D
CMR is capable of precisely measuring subtle alterations
in aortic lesions over time; a change of >5 % in plaque size
can be accurately detected [2, 19].
Given the abundance of different CMR sequences,
it is desirable to reach consensus on which CMR se-
quence is most appropriate for early identification and
Table 4 Intra-rater reproducibility
ICCa 95 % CIa Mean difference (SD)a 95 % LOAa
Intra-rater (non-contrast enhanced)a
- Mean aortic lumen area (cm2)a 0.99* 0.95, 1.00 0.02 (0.07) −0.13, 0.17
- Mean aortic total vessel area (cm2)a 0.99* 0.96, 1.00 0.04 (0.07) −0.10, 0.18
- Mean aortic wall area (cm2)a 0.98* 0.92, 0.99 0.01 (0.03) −0.05, 0.07
- Mean aortic wall thickness (mm)a 0.95* 0.82, 0.99 0.01 (0.06) −0.10, 0.13
- Maximum aortic wall thickness (mm)a 0.92* 0.73, 0.98 0.05 (0.11) −0.16, 0.25
- Mean aortic WA/TVA ratioa 0.91* 0.69, 0.98 0.00 (0.01) −0.02, 0.02
Intra-rater (contrast-enhanced)a
- Mean aortic lumen area (cm2)a 0.98* 0.91, 0.99 0.02 (0.09) −0.17, 0.20
- Mean aortic total vessel area (cm2)a 0.99* 0.94, 1.00 0.04 (0.09) −0.13, 0.21
- Mean aortic wall area (cm2)a 0.98* 0.77, 1.00 0.02 (0.02) −0.03, 0.07
- Mean aortic wall thickness (mm)a 0.93* 0.76, 0.98 0.03 (0.05) −0.07, 0.12
- Maximum aortic wall thickness (mm)a 0.96* 0.83, 0.99 0.00 (0.08) −0.16, 0.16
- Mean aortic WA/TVA ratioa 0.91* 0.71, 0.98 0.00 (0.01) −0.02, 0.03
* P < .001
aICC: intraclass correlation coefficient (two-way random effects model assessing absolute agreement of single measures). CI: confidence interval. LOA: limits of
agreement. WA: wall area. TVA: total vessel area
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subsequent monitoring of aortic atherosclerosis burden
[6–8, 10–12, 22]. Currently, there is an ongoing devel-
opment of CMR sequences that aim to optimize aor-
tic atherosclerosis quantification. A number of these
sequences have shown to be feasible for the quantifi-
cation of aortic atherosclerosis burden in a highly repro-
ducible manner in healthy subjects and in subjects with
CVD [6–8, 10–12, 22]. To date 2D Double Inversion Re-
covery (DIR) imaging remains the most commonly used
CMR technique for evaluation of the aortic wall [11, 24].
The majority of aortic CMR studies and proposed se-
quences to date have been performed at 1.5 T using 2D
BB techniques and a slice thickness of 4-5 mm. Addition-
ally, they provided limited aortic coverage due to time
Fig. 5 Sample size estimates based on pre-specified differences in aortic wall characteristics between groups. Overview of required sample sizes
to detect a mean difference between groups of 15, 12, 10, 7 and 5 % in mean aortic lumen area (a), mean total aortic vessel area (b), mean aortic
wall area (c), mean aortic wall thickness (d), maximum aortic wall thickness (e) and mean aortic WA/TVA ratio (f)
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constraints [7, 8, 10–12, 22, 24]. The present study was
performed at a 3.0 T system prepared with a dual-source
RF-transmission system, allowing for a higher SNR than a
1.5 T system and thus increases spatial resolution [25].
Additionally, this study used a 3D BB sequence. Prior
studies have shown that 2D and 3D sequences provide
similar morphometric measurements of the aorta. These
studies suggest that major benefits of 3D imaging as com-
pared to 2D imaging are the rise in SNR, the ability to
reformat the data in any desired orientation with MPR,
more detailed coverage of the arterial wall, the reduction
in examination duration, the augmented visualization of
small plaque constituents and the improved reproducibil-
ity (due to smaller slice thicknesses and enlarged flexibility
in co-image registration when performing a sequential
study) [6, 12, 26–28]. Moreover, a slice thickness of
1.2 mm was used, thereby reducing partial volume effects
and providing a high isotropic resolution, which may
reduce variability in measurement as compared to se-
quences that use a larger slice thickness [8]. Hence, in
contrast to prior studies, the 3D-T1-BB-VISTA sequence
is likely to improve visualization and delineation of the
aortic wall and as such allows for an enhanced accuracy
and quantification of measurement. In addition, the stud-
ied sequence is capable of covering approximately 35 cm
of aorta within an acceptable scan time, enabling us to
assess its reproducibility, and thus possibly aortic athero-
sclerosis, over a larger aortic territory and a wide range of
aortic sizes. Another advantage of the 3D-T1-BB-VISTA
sequence is that it can be used before and after contrast
agent administration and thus can directly compare signal
intensity before and after contrast agent administration.
As such, it may be of value for evaluation of plaque bur-
den, composition and neovascularization [2, 29]. In this
study we demonstrated no relevant differences in arterial
wall area and thickness between the non-contrast en-
hanced and contrast-enhanced acquisitions, implying that
slow flow artefacts, which possibly decrease the accuracy
of measurement, may not be an issue when using the 3D-
T1-BB-VISTA sequence in healthy subjects. Yet, this ob-
servation does require further evaluation in other cohorts.
In addition, a direct comparison of the reproducibility be-
tween the 3D-T1-BB-VISTA sequence and 2D sequences
in young, healthy individuals remains to be performed.
Mihai and co-workers demonstrated an excellent re-
producibility of the 3D-T1-BB-VISTA sequence in 15
patients with CVD and 6 healthy volunteers [6]. Our
study extends these preliminary results to a much youn-
ger population. As opposed to Mihai and co-workers,
the present study did not evaluate the reproducibility of
the 3D-T1-BB-VISTA sequence at other locations than
the thoracic descending aorta. The reasons for this were
that atherosclerosis is known to develop first in the de-
scending aorta and that the SNR of the region below the
celiac trunk was insufficient when using a cardiac coil.
Yet, since atherosclerosis burden may exhibit different
characteristics in other vascular beds, the reproducibility
of the 3D-T1-BB-VISTA sequence in the young at other
locations than the thoracic descending aorta remains to
be determined. Another difference is that the present
study was solely performed in healthy young adults, who
aortas are not likely to already harbour large atheroscler-
otic plaques. In contrast, our results confirm the ability
of 3D-T1-BB-VISTA to detect subtle differences in aortic
wall thickness between subjects with excellent reproduci-
bility. Our findings are in accordance with the results of
Mihai and co-workers, who demonstrated an excellent
reproducibility of the 3D-T1-BB-VISTA sequence in pa-
tients with known CVD [6].
Our study has limitations. First, we did not use ECG
triggering or breath holding. Hence, pulsation and breath-
ing artefacts may have introduced slight errors in meas-
urement of absolute aortic wall characteristics. Despite
this limitation, reproducibility remained excellent. Never-
theless, tracking of motion using navigators or special
motion compensation methods may also improve 3D
sequences further. Second, due to time constraints, we
analysed one out of every eight slices acquired, thereby in-
ducing a wide gap between two analysed slices. As such,
possible focal atherosclerotic lesions may have remained
undetected. Yet, since atherosclerosis is conceived to be a
generalized disease, we expect the potential loss of infor-
mation to be minimal in young asymptomatic subjects.
Third, our choice of slice thickness created some chal-
lenges in preserving adequate signal to allow continuous
distinction of aortic wall boundaries in all slices. However,
we specifically chose not to use thicker slices since prior
studies on 3D BB aorta imaging also used slice thicknesses
of ~1 mm with good results [6, 12, 26]. In addition, no
slices had to be removed because of insufficient image
quality and reproducibility remained excellent between
scans as well as between and within raters. Moreover, we
believe that the large size of our dataset, our 3D sequence
and 3 T system have reduced the potential negative influ-
ence of our small slice thickness. Fourth, we did not use a
fully automatic image analysis tool for the measurement
of the aortic wall characteristics, which made quantifica-
tion time-consuming and possibly less accurate. Yet, since
vascular wall characteristics are usually in the range of a
few millimetres, accurate quantification is crucial for its
utility in atherosclerosis evaluation. The currently used
semi-automatic tool requires dedicated training of raters
in image analysis to achieve accurate quantification of
aortic wall characteristics, particularly when vascular wall
delineation between the vascular wall adventitia and en-
closing tissue is unclear. Employment of standardized
methods and fully automatic tools may increase efficiency
and accuracy of quantification, thereby enabling
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atherosclerosis detection and monitoring over a larger ter-
ritory and more homogeneity in measurement across
studies. Finally, our results provide an important first step
in the process of determining the utility of the 3D-T1-BB-
VISTA sequence for preclinical detection and monitoring
of atherosclerosis burden in early adult life, when vascular
wall abnormalities are still subtle. However, the relation of
the studied characteristics with CV risk factors and CVD
morbidity and mortality remains to be determined.
Conclusion
In conclusion 3D-T1-BB-VISTA sequence provides ex-
cellent reproducibility for quantification of aortic wall
characteristics and can detect differences of 5 % in aortic
wall characteristics between groups with a reasonable
sample size. It may be a valuable tool for assessment of
the subtle vascular wall changes of early atherosclerosis.
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